Free Trial

Exelon (EXC) Financials

Exelon logo
$44.41 -0.61 (-1.35%)
Closing price 05/7/2026 04:00 PM Eastern
Extended Trading
$44.65 +0.24 (+0.55%)
As of 06:23 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Exelon

Annual Income Statements for Exelon

This table shows Exelon's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
1,697 1,121 3,779 2,005 2,936 1,963 1,706 2,170 2,328 2,460 2,768
Consolidated Net Income / (Loss)
1,669 1,196 3,869 2,079 3,028 1,954 1,829 2,171 2,328 2,460 2,768
Net Income / (Loss) Continuing Operations
0.00 32,514 3,869 2,079 3,028 1,099 1,616 2,054 0.00 0.00 0.00
Total Pre-Tax Income
3,330 1,973 3,775 2,225 3,985 1,092 1,654 2,403 2,702 2,667 3,291
Total Operating Income
2,748 34,530 4,388 3,891 4,374 2,191 2,682 3,315 4,023 4,319 5,148
Total Gross Profit
2,730 40,090 9,498 19,308 10,326 6,301 7,006 8,032 8,927 9,405 10,414
Total Revenue
11,052 62,684 33,558 35,978 34,438 16,663 17,938 19,078 21,727 23,028 24,258
Operating Revenue
11,052 62,684 33,558 35,978 34,438 16,663 17,938 19,078 21,727 23,028 24,258
Total Cost of Revenue
8,322 22,594 24,060 16,670 24,112 10,362 10,932 11,046 12,800 13,623 13,844
Operating Cost of Revenue
8,322 22,594 24,060 16,670 24,112 10,362 10,932 11,046 12,800 13,623 13,844
Total Operating Expenses
-18 5,560 5,110 15,417 5,952 4,110 4,324 4,717 4,904 5,086 5,266
Depreciation Expense
- 3,936 3,828 4,353 4,252 2,891 3,033 3,325 3,506 3,594 3,640
Other Operating Expenses / (Income)
0.00 1,576 1,518 11,120 1,731 1,232 1,291 1,390 1,408 1,504 1,629
Other Special Charges / (Income)
-18 48 -236 -56 -31 -13 0.00 2.00 -10 -12 -3.00
Total Other Income / (Expense), net
-1,079 -1,239 -613 -1,666 -389 -1,099 -1,028 -912 -1,321 -1,652 -1,857
Interest Expense
- 1,536 1,560 1,554 1,616 1,307 1,289 1,447 1,729 1,914 2,127
Other Income / (Expense), net
- 297 947 -112 1,227 208 261 535 408 262 270
Income Tax Expense
- 753 -126 118 774 -7.00 38 349 374 207 523
Net Income / (Loss) Discontinued Operations
- - - - - 855 213 117 0.00 0.00 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest
-28 75 90 74 92 -9.00 123 1.00 0.00 0.00 0.00
Weighted Average Basic Shares Outstanding
890M 924M 947M 967M 973M 976M 979M 986M 996M 1.00B 1.01B
Weighted Average Diluted Shares Outstanding
893M 927M 949M 969M 974M 977M 980M 987M 997M 1.00B 1.01B
Weighted Average Basic & Diluted Shares Outstanding
890M 924M 946.50M 966.30M 973M 2.56B 1.29B 1.30B 1.31B 1.31B 1.33B
Cash Dividends to Common per Share
$1.24 $0.00 $1.31 $1.38 $1.45 $1.53 $1.53 $1.35 $1.44 $1.52 $1.60

Quarterly Income Statements for Exelon

This table shows Exelon's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
700 616 658 448 707 647 908 391 875 594 919
Consolidated Net Income / (Loss)
700 616 658 448 707 647 908 391 875 594 919
Net Income / (Loss) Continuing Operations
700 616 658 448 707 647 908 391 875 -2,174 919
Total Pre-Tax Income
767 716 721 494 757 695 1,078 461 1,030 722 1,119
Total Operating Income
1,123 1,090 1,114 913 1,196 1,096 1,536 927 1,500 1,185 1,605
Total Gross Profit
3,583 -1,219 2,362 2,160 2,496 -1,368 2,845 2,210 2,841 2,518 3,000
Total Revenue
5,980 5,366 6,043 5,361 6,154 5,470 6,714 5,427 6,705 5,412 7,242
Operating Revenue
5,980 5,366 6,043 5,361 6,154 5,470 6,714 5,427 6,705 5,412 7,242
Total Cost of Revenue
2,397 6,585 3,681 3,201 3,658 6,838 3,869 3,217 3,864 2,894 4,242
Operating Cost of Revenue
2,397 6,585 3,681 3,201 3,658 6,838 3,869 3,217 3,864 2,894 4,242
Total Operating Expenses
2,460 -2,309 1,248 1,247 1,300 -2,471 1,309 1,283 1,341 1,333 1,395
Depreciation Expense
890 890 879 894 908 913 903 902 912 923 952
Other Operating Expenses / (Income)
383 346 371 360 395 378 405 383 429 412 443
Other Special Charges / (Income)
0.00 - -2.00 -7.00 -3.00 - 1.00 -2.00 0.00 -2.00 0.00
Total Other Income / (Expense), net
-356 -374 -393 -419 -439 -401 -458 -466 -470 -463 -486
Interest Expense
437 453 468 483 496 467 510 531 538 548 555
Other Income / (Expense), net
81 79 75 64 57 66 52 65 68 85 69
Income Tax Expense
67 100 63 46 50 48 170 70 155 128 200
Basic Earnings per Share
$0.70 $0.62 $0.66 $0.45 $0.70 - $0.90 $0.39 $0.87 - $0.90
Weighted Average Basic Shares Outstanding
996M 996M 1B 1.00B 1.00B 1.00B 1.01B 1.01B 1.01B 1.01B 1.02B
Diluted Earnings per Share
$0.70 $0.62 $0.66 $0.45 $0.70 - $0.90 $0.39 $0.86 - $0.90
Weighted Average Diluted Shares Outstanding
997M 997M 1.00B 1.00B 1.00B 1.00B 1.01B 1.01B 1.01B 1.01B 1.03B
Weighted Average Basic & Diluted Shares Outstanding
1.30B 1.31B 1.31B 1.31B 1.31B 1.31B 1.32B 1.32B 1.32B 1.33B 1.33B
Cash Dividends to Common per Share
$0.36 $0.36 $0.38 $0.38 - - $0.40 $0.40 - - $0.42

Annual Cash Flow Statements for Exelon

This table details how cash moves in and out of Exelon's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
4,624 -5,798 276 -3,841 -659 44 453 -529 11 -162 262
Net Cash From Operating Activities
7,616 8,461 7,480 4,303 6,659 4,235 3,012 4,870 4,703 5,569 6,254
Net Cash From Continuing Operating Activities
7,558 8,461 6,024 4,303 5,433 5,533 3,012 4,870 4,703 5,569 6,254
Net Income / (Loss) Continuing Operations
2,250 1,196 3,869 0.00 3,028 1,954 1,829 2,171 2,328 2,460 2,768
Consolidated Net Income / (Loss)
2,250 1,196 3,869 - 3,028 1,954 1,829 2,171 2,328 2,460 2,768
Depreciation Expense
3,987 5,576 5,427 5,971 5,780 6,527 7,573 3,533 3,506 3,596 3,643
Non-Cash Adjustments To Reconcile Net Income
1,643 2,138 -169 -1,217 1,027 553 -940 833 -4.00 708 986
Changes in Operating Assets and Liabilities, net
-322 -449 -1,647 -451 -3,176 -4,799 -5,450 -1,667 -1,127 -1,195 -1,143
Net Cash From Investing Activities
-7,822 -15,450 -7,971 -7,925 -7,260 -4,336 -3,317 -6,990 -7,375 -7,042 -8,525
Net Cash From Continuing Investing Activities
-7,822 -15,450 -7,971 -7,925 -7,260 -4,336 -3,317 -6,990 -7,375 -7,042 -8,525
Purchase of Property, Plant & Equipment
-7,624 -8,553 -7,584 -7,594 -7,248 -8,048 -7,981 -7,147 -7,408 -7,097 -8,529
Purchase of Investments
-7,147 -9,738 -8,113 -8,997 -10,087 -3,464 -6,673 -516 0.00 0.00 0.00
Sale of Property, Plant & Equipment
147 61 219 - 53 46 877 16 25 38 4.00
Sale and/or Maturity of Investments
6,895 9,496 7,845 8,762 10,051 3,341 6,532 488 0.00 0.00 0.00
Other Investing Activities, net
-53 207 -43 58 12 3,789 3,928 169 8.00 17 0.00
Net Cash From Financing Activities
4,830 1,191 767 -219 -58 145 758 1,591 2,683 1,311 2,533
Net Cash From Continuing Financing Activities
4,830 1,183 767 -219 -58 145 758 1,591 2,683 1,311 2,533
Repayment of Debt
-2,706 -2,836 -3,784 -1,895 -713 -6,415 -1,801 -2,689 -2,290 -2,480 -2,652
Payment of Dividends
-1,105 -1,174 -1,236 -1,332 -1,408 -1,492 -2,382 -1,334 -1,433 -1,524 -1,617
Issuance of Debt
6,709 4,956 4,091 2,903 1,951 8,007 4,861 7,609 6,225 5,124 6,075
Issuance of Common Equity
1,932 427 1,696 105 112 45 80 599 181 191 727
Other Financing Activities, net
0.00 0.00 - 0.00 0.00 0.00 0.00 -2,594 0.00 0.00 0.00

Quarterly Cash Flow Statements for Exelon

This table details how cash moves in and out of Exelon's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
-88 154 207 227 -302 -294 643 -331 847 -897 96
Net Cash From Operating Activities
1,531 1,411 992 1,462 1,689 1,426 1,200 1,511 2,299 1,244 1,724
Net Cash From Continuing Operating Activities
1,531 1,411 992 1,462 1,689 1,426 1,200 1,511 2,299 1,244 1,724
Net Income / (Loss) Continuing Operations
699 617 658 448 707 647 908 392 874 594 919
Consolidated Net Income / (Loss)
699 617 658 448 707 647 908 392 874 594 919
Depreciation Expense
889 890 880 894 909 913 905 901 913 924 953
Non-Cash Adjustments To Reconcile Net Income
118 2.00 84 225 -20 419 467 435 481 -397 567
Changes in Operating Assets and Liabilities, net
-175 -98 -630 -105 93 -553 -1,080 -217 31 123 -715
Net Cash From Investing Activities
-1,840 -1,860 -1,767 -1,700 -1,647 -1,928 -1,942 -2,020 -2,138 -2,425 -2,356
Net Cash From Continuing Investing Activities
-1,840 -1,860 -1,767 -1,700 -1,647 -1,928 -1,942 -2,020 -2,138 -2,425 -2,356
Purchase of Property, Plant & Equipment
-1,855 -1,868 -1,767 -1,699 -1,695 -1,936 -1,946 -2,013 -2,136 -2,434 -2,358
Sale of Property, Plant & Equipment
- 25 2.00 - - - 0.00 2.00 - 2.00 0.00
Other Investing Activities, net
15 -17 -2.00 1.00 10 8.00 4.00 -9.00 -2.00 7.00 2.00
Net Cash From Financing Activities
221 603 982 465 -344 208 1,385 178 686 284 728
Net Cash From Continuing Financing Activities
221 603 982 465 -344 208 1,385 178 686 284 728
Repayment of Debt
467 286 -1,423 -766 221 -247 -810 -803 -48 -991 -474
Payment of Dividends
-357 -359 -381 -380 -381 -382 -403 -405 -404 -405 -430
Issuance of Debt
100 525 2,775 1,600 -343 827 2,425 1,375 1,125 1,150 1,620
Issuance of Common Equity
11 151 11 11 159 10 173 11 13 530 12

Annual Balance Sheets for Exelon

This table presents Exelon's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
95,384 114,904 116,770 119,634 124,977 129,317 133,013 95,349 101,856 107,784 116,570
Total Current Assets
15,334 12,412 11,896 13,328 12,037 12,562 13,957 7,336 8,087 8,384 9,546
Cash & Equivalents
6,502 635 898 1,349 587 663 672 407 445 357 626
Restricted Cash
205 253 207 247 358 438 321 566 482 541 525
Accounts Receivable
912 5,359 5,577 5,863 6,223 4,700 2,865 3,561 3,361 3,754 5,082
Inventories, net
1,566 1,638 1,651 1,685 1,768 1,722 581 755 801 1,022 868
Prepaid Expenses
- - - - - - - - 413 494 563
Other Current Assets
2,962 3,277 3,563 3,280 3,149 4,152 1,683 2,047 2,585 2,385 1,882
Plant, Property, & Equipment, net
57,439 71,555 74,202 76,707 80,233 82,584 64,558 69,076 73,593 78,182 84,318
Total Noncurrent Assets
22,405 30,937 30,672 29,599 32,707 34,171 54,498 18,937 20,176 21,958 22,706
Long-Term Investments
639 629 640 625 464 440 250 232 251 290 312
Noncurrent Note & Lease Receivables
0.00 - 0.00 0.00 0.00 0.00 0.00 2,897 3,232 4,026 4,755
Goodwill
2,672 6,677 6,677 6,677 6,677 6,677 6,630 6,630 6,630 6,630 6,630
Employee Benefit Assets
- - 0.00 0.00 0.00 0.00 - 0.00 0.00 657 0.00
Other Noncurrent Operating Assets
19,094 23,631 23,355 22,297 25,566 27,054 9,109 9,178 10,063 10,355 11,009
Total Liabilities & Shareholders' Equity
95,384 114,904 116,770 119,634 124,977 129,317 133,013 95,349 101,856 107,784 116,570
Total Liabilities
68,062 87,292 84,583 86,587 90,404 94,449 98,218 70,605 76,101 80,863 87,772
Total Current Liabilities
9,118 13,457 10,798 11,404 14,185 12,771 16,111 10,611 9,901 9,611 10,331
Short-Term Debt
2,033 3,697 3,017 2,063 6,080 3,850 3,401 4,388 3,926 3,312 2,277
Accounts Payable
3,193 3,441 3,889 3,805 3,565 3,567 2,384 3,387 2,851 4,098 3,726
Accrued Expenses
2,376 3,460 1,837 2,112 1,981 2,078 1,137 1,226 1,375 1,468 1,582
Customer Deposits
0.00 - 0.00 0.00 0.00 - - - 411 446 533
Other Current Liabilities
1,516 2,700 2,055 2,647 2,559 2,901 1,249 1,610 1,338 1,386 2,213
Total Noncurrent Liabilities
58,854 73,835 73,785 75,183 76,219 81,678 82,107 59,994 66,200 86,684 77,441
Long-Term Debt
23,645 31,575 32,176 34,075 31,329 35,093 30,749 35,662 40,082 58,769 47,803
Asset Retirement Reserve & Litigation Obligation
13,807 14,336 21,041 20,409 22,031 22,993 9,899 9,381 9,843 10,499 11,337
Noncurrent Deferred & Payable Income Tax Liabilities
13,776 18,138 11,235 11,321 12,351 13,035 10,611 11,250 11,956 12,793 13,715
Noncurrent Employee Benefit Liabilities
5,003 6,096 5,829 5,916 6,323 6,514 2,862 1,616 2,098 2,217 2,295
Other Noncurrent Operating Liabilities
1,982 3,049 3,504 3,462 4,185 4,043 2,310 2,085 2,221 2,406 2,291
Total Equity & Noncontrolling Interests
27,294 27,612 32,187 33,047 34,573 34,868 34,795 24,744 25,755 26,921 28,798
Total Preferred & Common Equity
25,793 25,837 29,896 30,741 32,224 32,585 34,393 24,744 25,755 26,921 28,798
Total Common Equity
25,793 25,837 29,896 30,741 32,224 32,585 34,393 24,744 0.00 0.00 28,798
Common Stock
18,676 18,794 18,964 19,116 19,274 19,373 20,324 20,908 21,114 21,338 22,106
Retained Earnings
12,068 12,030 14,081 14,743 16,267 16,735 16,942 4,597 5,490 6,426 7,577
Treasury Stock
-2,327 -2,327 -123 -123 -123 -123 -123 -123 -123 -123 -123
Accumulated Other Comprehensive Income / (Loss)
-2,624 -2,660 -3,026 -2,995 -3,194 -3,400 -2,750 -638 -726 -720 -762
Other Equity Adjustments
- - 0.00 0.00 0.00 0.00 - - - - 0.00

Quarterly Balance Sheets for Exelon

This table presents Exelon's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
98,080 99,259 101,856 103,211 105,113 106,070 107,784 109,484 111,147 113,539 117,545
Total Current Assets
7,542 7,519 8,087 8,212 8,557 8,023 8,384 8,799 8,676 9,229 9,002
Cash & Equivalents
399 300 445 720 934 616 357 1,004 724 1,533 713
Restricted Cash
435 435 482 489 530 552 541 578 478 516 560
Accounts Receivable
3,125 3,314 3,361 3,585 3,709 3,660 3,754 4,016 4,113 3,999 4,692
Inventories, net
710 762 801 788 824 855 853 833 868 888 846
Prepaid Expenses
- - 413 - - - 494 240 349 445 314
Other Current Assets
2,968 2,708 2,585 2,630 2,560 2,340 2,385 2,128 2,144 1,848 1,877
Plant, Property, & Equipment, net
71,300 72,458 73,593 74,604 75,646 76,661 78,182 79,177 80,609 82,100 85,564
Total Noncurrent Assets
19,238 19,282 20,176 20,395 20,910 21,386 21,218 21,508 21,862 22,210 22,979
Long-Term Investments
238 246 251 263 270 279 290 289 297 307 317
Noncurrent Note & Lease Receivables
3,120 2,923 3,232 3,382 3,840 4,322 4,026 4,110 4,411 4,658 4,830
Goodwill
6,630 6,630 6,630 6,630 6,630 6,630 6,630 6,630 6,630 6,630 6,630
Employee Benefit Assets
0.00 - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Noncurrent Operating Assets
9,250 9,483 10,063 10,120 10,170 10,155 10,272 10,479 10,524 10,615 11,202
Total Liabilities & Shareholders' Equity
98,080 99,259 101,856 103,211 105,113 106,070 107,784 109,484 111,147 113,539 117,545
Total Liabilities
73,001 73,789 76,101 77,150 78,961 79,448 80,863 81,877 83,527 85,426 88,230
Total Current Liabilities
7,936 8,800 9,901 7,975 8,275 7,384 9,611 8,103 9,156 9,825 9,588
Short-Term Debt
2,741 3,374 3,926 2,709 2,762 1,985 3,312 2,538 2,927 3,248 2,991
Accounts Payable
0.00 2,689 2,851 2,819 2,815 2,653 2,999 2,698 3,048 3,245 3,124
Accrued Expenses
1,220 1,315 1,375 1,076 1,241 1,284 1,468 1,186 1,318 1,414 1,203
Customer Deposits
- - 411 419 425 432 446 465 486 507 565
Other Current Liabilities
1,464 1,422 1,338 952 1,032 1,030 1,386 1,216 1,377 1,411 1,705
Total Noncurrent Liabilities
65,454 64,989 66,200 69,175 70,686 72,064 71,252 73,774 74,371 75,601 78,642
Long-Term Debt
40,271 39,821 40,082 42,661 43,429 44,091 43,337 45,732 45,917 46,673 48,249
Asset Retirement Reserve & Litigation Obligation
9,679 9,505 9,843 9,976 10,470 10,852 10,499 10,594 10,952 11,207 11,507
Noncurrent Deferred & Payable Income Tax Liabilities
11,547 11,792 11,956 12,199 12,358 12,551 12,793 13,081 13,221 13,519 14,201
Noncurrent Employee Benefit Liabilities
1,571 1,600 2,098 2,092 2,086 2,081 2,217 1,955 1,964 1,973 1,984
Other Noncurrent Operating Liabilities
2,386 2,271 2,221 2,247 2,343 2,489 2,406 2,412 2,317 2,229 2,701
Total Equity & Noncontrolling Interests
25,079 25,470 25,755 26,061 26,152 26,622 26,921 27,607 27,620 28,113 29,315
Total Preferred & Common Equity
25,079 25,470 25,755 26,061 26,152 26,622 26,921 27,607 27,620 28,113 29,315
Total Common Equity
25,079 25,470 0.00 26,061 26,152 26,622 0.00 27,607 27,620 28,113 29,315
Common Stock
20,941 20,956 21,114 21,129 21,152 21,320 21,338 21,517 21,544 21,564 22,129
Retained Earnings
4,891 5,233 5,490 5,767 5,835 6,161 6,426 6,931 6,917 7,387 8,065
Treasury Stock
-123 -123 -123 -123 -123 -123 -123 -123 -123 -123 -123
Accumulated Other Comprehensive Income / (Loss)
-630 -596 -726 -712 -712 -736 -720 -718 -718 -715 -756
Other Equity Adjustments
- 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 0.00

Annual Metrics And Ratios for Exelon

This table displays calculated financial ratios and metrics derived from Exelon's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-92.15% 467.17% -46.46% 7.21% -4.28% -51.61% 7.65% 6.36% 13.89% 5.99% 5.34%
EBITDA Growth
-36.89% 499.90% -73.36% -9.40% 16.73% -21.57% 17.81% -29.79% 7.50% 3.02% 10.81%
EBIT Growth
-59.61% 1,167.36% -84.68% -29.17% 48.21% -57.17% 22.68% 30.82% 15.09% 3.39% 18.27%
NOPAT Growth
-54.54% 676.98% -78.76% -18.74% -4.35% -37.44% 18.84% 8.13% 22.33% 14.93% 8.69%
Net Income Growth
-69.38% -28.34% 223.50% -46.27% 45.65% -35.47% -6.40% 18.70% 7.23% 5.67% 12.52%
EPS Growth
35.11% -52.36% 228.93% -47.99% 45.65% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Growth
70.88% 11.10% -11.59% -42.47% 54.75% -36.40% -28.88% 61.69% -3.43% 18.41% 12.30%
Free Cash Flow Firm Growth
213.74% -72.08% -51.00% 132.79% -108.52% 615.73% 1,672.01% -129.90% 73.54% 112.21% -225.30%
Invested Capital Growth
-10.51% 44.60% 5.58% 1.83% 5.59% 1.58% -23.31% 15.67% 7.86% 5.54% 6.65%
Revenue Q/Q Growth
-91.18% 87.60% -16.78% 1.20% -1.33% -49.91% 24.49% 0.00% 0.00% 0.45% -0.24%
EBITDA Q/Q Growth
-54.74% 43.58% -37.84% -10.73% 8.58% 3.98% 107.79% 82.39% 128.73% 0.20% 1.33%
EBIT Q/Q Growth
-74.88% 50.94% -54.58% -24.16% 21.00% -43.66% 116.40% 0.00% 0.00% -0.15% 2.03%
NOPAT Q/Q Growth
-64.12% 32.19% -46.09% -27.26% 2.13% -29.52% 213.88% 0.00% 0.00% 2.22% -0.97%
Net Income Q/Q Growth
105.32% 79.58% 78.21% -46.92% 30.46% -16.03% -2.51% 0.00% 0.00% 1.28% -1.88%
EPS Q/Q Growth
0.00% 0.00% 80.09% -46.79% 30.46% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
49.04% -9.07% 10.47% -49.27% 5,992.92% -0.45% -64.66% 61.69% 16.96% 0.27% -2.83%
Free Cash Flow Firm Q/Q Growth
-83.43% 105.51% -82.05% -4.76% -125.52% -12.54% -74.47% 91.14% 75.52% -43.47% -764.31%
Invested Capital Q/Q Growth
617.49% 0.83% 2.36% 0.38% 1.98% 0.85% 1,544.02% 3.51% 1.33% 1.59% 1.74%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
24.70% 63.96% 28.30% 53.67% 29.98% 37.81% 39.06% 42.10% 41.09% 40.84% 42.93%
EBITDA Margin
60.94% 64.46% 32.07% 27.10% 33.05% 53.57% 58.62% 38.70% 36.53% 35.51% 37.35%
Operating Margin
24.86% 55.09% 13.08% 10.81% 12.70% 13.15% 14.95% 17.38% 18.52% 18.76% 21.22%
EBIT Margin
24.86% 55.56% 15.90% 10.50% 16.26% 14.40% 16.41% 20.18% 20.39% 19.89% 22.33%
Profit (Net Income) Margin
15.10% 1.91% 11.53% 5.78% 8.79% 11.73% 10.20% 11.38% 10.71% 10.68% 11.41%
Tax Burden Percent
50.12% 60.62% 102.49% 93.44% 75.98% 178.94% 110.58% 90.35% 86.16% 92.24% 84.11%
Interest Burden Percent
121.18% 5.67% 70.76% 58.88% 71.15% 45.52% 56.20% 62.42% 60.98% 58.22% 60.74%
Effective Tax Rate
0.00% 38.17% -3.34% 5.30% 19.42% -0.64% 2.30% 14.52% 13.84% 7.76% 15.89%
Return on Invested Capital (ROIC)
6.04% 40.61% 7.10% 5.56% 5.13% 3.10% 4.14% 4.78% 5.24% 5.65% 5.80%
ROIC Less NNEP Spread (ROIC-NNEP)
0.40% -39.61% 5.14% 0.79% 3.71% 2.41% 1.36% 2.53% 2.46% 2.20% 2.46%
Return on Net Nonoperating Assets (RNNOA)
0.29% -36.25% 5.84% 0.81% 3.83% 2.53% 1.11% 2.51% 3.98% 3.69% 4.13%
Return on Equity (ROE)
6.32% 4.36% 12.94% 6.37% 8.96% 5.63% 5.25% 7.29% 9.22% 9.34% 9.94%
Cash Return on Invested Capital (CROIC)
17.13% 4.14% 1.67% 3.75% -0.31% 1.53% 30.53% -9.75% -2.31% 0.27% -0.63%
Operating Return on Assets (OROA)
3.30% 33.12% 4.61% 3.20% 4.58% 1.89% 2.24% 3.37% 4.49% 4.37% 4.83%
Return on Assets (ROA)
2.00% 1.14% 3.34% 1.76% 2.48% 1.54% 1.39% 1.90% 2.36% 2.35% 2.47%
Return on Common Equity (ROCE)
6.12% 4.10% 12.06% 5.92% 8.34% 5.25% 5.05% 7.24% 4.52% 0.00% 0.00%
Return on Equity Simple (ROE_SIMPLE)
6.47% 4.63% 12.94% 6.76% 9.40% 6.00% 5.32% 8.77% 9.04% 9.14% 0.00%
Net Operating Profit after Tax (NOPAT)
2,748 21,352 4,534 3,685 3,524 2,205 2,620 2,834 3,466 3,984 4,330
NOPAT Margin
24.86% 34.06% 13.51% 10.24% 10.23% 13.23% 14.61% 14.85% 15.95% 17.30% 17.85%
Net Nonoperating Expense Percent (NNEP)
5.64% 80.22% 1.96% 4.78% 1.42% 0.69% 2.78% 2.25% 2.79% 3.45% 3.34%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 4.37% 4.97% 5.42% 4.48%
Cost of Revenue to Revenue
75.30% 36.04% 71.70% 46.33% 70.02% 62.19% 60.94% 57.90% 58.91% 59.16% 57.07%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
-0.16% 8.87% 15.23% 42.85% 17.28% 24.67% 24.11% 24.72% 22.57% 22.09% 21.71%
Earnings before Interest and Taxes (EBIT)
2,748 34,827 5,335 3,779 5,601 2,399 2,943 3,850 4,431 4,581 5,418
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
6,735 40,403 10,762 9,750 11,381 8,926 10,516 7,383 7,937 8,177 9,061
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.96 1.29 1.32 1.53 1.53 1.46 1.96 2.10 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
1.08 1.74 1.70 1.95 1.93 1.83 2.42 2.87 0.00 0.00 0.00
Price to Revenue (P/Rev)
2.25 0.53 1.18 1.31 1.43 2.85 3.75 2.73 2.06 2.14 2.37
Price to Earnings (P/E)
14.66 29.75 10.47 23.45 16.77 24.17 39.44 23.99 19.27 20.06 20.73
Dividend Yield
6.07% 4.66% 4.20% 3.74% 3.77% 4.13% 2.92% 3.37% 4.18% 4.04% 3.67%
Earnings Yield
6.82% 3.36% 9.55% 4.26% 5.96% 4.14% 2.54% 4.17% 5.19% 4.99% 4.82%
Enterprise Value to Invested Capital (EV/IC)
1.04 1.11 1.15 1.25 1.24 1.22 1.83 1.43 1.28 1.31 1.61
Enterprise Value to Revenue (EV/Rev)
4.05 1.10 2.24 2.31 2.54 5.23 5.61 4.77 4.04 4.12 5.10
Enterprise Value to EBITDA (EV/EBITDA)
6.64 1.70 7.00 8.54 7.70 9.76 9.57 12.31 11.05 11.59 13.66
Enterprise Value to EBIT (EV/EBIT)
16.27 1.98 14.11 22.03 15.64 36.32 34.18 23.61 19.79 20.69 22.85
Enterprise Value to NOPAT (EV/NOPAT)
16.27 3.23 16.60 22.59 24.85 39.52 38.39 32.08 25.30 23.80 28.59
Enterprise Value to Operating Cash Flow (EV/OCF)
5.87 8.14 10.07 19.35 13.15 20.58 33.40 18.67 18.64 17.02 19.79
Enterprise Value to Free Cash Flow (EV/FCFF)
5.74 31.65 70.60 33.53 0.00 79.87 5.20 0.00 0.00 507.56 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.94 1.28 1.09 1.09 1.08 1.12 0.98 1.62 1.71 1.73 2.36
Long-Term Debt to Equity
0.87 1.14 1.00 1.03 0.91 1.01 0.88 1.44 1.56 1.61 2.28
Financial Leverage
0.72 0.92 1.14 1.03 1.03 1.05 0.82 0.99 1.62 1.68 1.68
Leverage Ratio
3.16 3.83 3.87 3.62 3.62 3.66 3.77 3.84 3.91 3.98 4.03
Compound Leverage Factor
3.83 0.22 2.74 2.13 2.57 1.67 2.12 2.39 2.38 2.32 2.45
Debt to Total Capital
48.47% 56.09% 52.23% 52.23% 51.97% 52.76% 49.53% 61.81% 63.08% 63.41% 70.21%
Short-Term Debt to Total Capital
3.84% 5.88% 4.48% 2.98% 8.45% 5.22% 4.93% 6.77% 5.63% 4.50% 2.36%
Long-Term Debt to Total Capital
44.64% 50.21% 47.75% 49.25% 43.52% 47.54% 44.60% 55.04% 57.45% 58.91% 67.85%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
2.83% 2.82% 3.40% 3.33% 3.26% 3.09% 0.58% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
48.69% 41.09% 44.37% 44.43% 44.77% 44.15% 49.88% 38.19% 0.00% 0.00% 0.00%
Debt to EBITDA
3.81 0.87 3.27 3.71 3.29 4.36 3.25 5.42 5.54 5.70 7.49
Net Debt to EBITDA
2.72 0.84 3.11 3.48 3.16 4.19 3.13 5.26 5.40 5.56 7.33
Long-Term Debt to EBITDA
3.51 0.78 2.99 3.49 2.75 3.93 2.92 4.83 5.05 5.30 7.24
Debt to NOPAT
9.34 1.65 7.76 9.81 10.61 17.66 13.03 14.13 12.70 11.71 15.67
Net Debt to NOPAT
6.67 1.58 7.38 9.21 10.21 16.96 12.56 13.71 12.36 11.41 15.34
Long-Term Debt to NOPAT
8.60 1.48 7.10 9.25 8.89 15.91 11.73 12.59 11.56 10.88 15.15
Altman Z-Score
0.69 1.91 0.90 0.92 0.91 0.67 0.78 0.80 0.76 0.79 0.84
Noncontrolling Interest Sharing Ratio
3.21% 5.97% 6.80% 7.05% 6.88% 6.67% 3.85% 0.68% 51.00% 100.00% 100.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.68 0.92 1.10 1.17 0.85 0.98 0.87 0.69 0.82 0.87 0.92
Quick Ratio
0.81 0.45 0.60 0.63 0.48 0.41 0.22 0.37 0.38 0.43 0.55
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
7,795 2,177 1,066 2,483 -212 1,091 19,333 -5,781 -1,530 187 -472
Operating Cash Flow to CapEx
101.86% 99.64% 101.56% 56.66% 92.55% 52.92% 42.40% 68.29% 63.70% 78.89% 73.36%
Free Cash Flow to Firm to Interest Expense
0.00 1.42 0.68 1.60 -0.13 0.83 15.00 -4.00 -0.88 0.10 -0.22
Operating Cash Flow to Interest Expense
0.00 5.51 4.79 2.77 4.12 3.24 2.34 3.37 2.72 2.91 2.94
Operating Cash Flow Less CapEx to Interest Expense
0.00 -0.02 0.07 -2.12 -0.33 -2.88 -3.17 -1.56 -1.55 -0.78 -1.07
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.13 0.60 0.29 0.30 0.28 0.13 0.14 0.17 0.22 0.22 0.22
Accounts Receivable Turnover
0.00 19.99 6.14 6.29 5.70 3.05 4.74 5.94 6.28 6.47 5.49
Inventory Turnover
5.25 14.10 14.63 9.99 13.97 5.94 9.49 16.54 16.45 16.47 13.41
Fixed Asset Turnover
0.20 0.97 0.46 0.48 0.44 0.20 0.24 0.29 0.30 0.30 0.30
Accounts Payable Turnover
4.92 6.81 6.56 4.33 6.54 2.91 3.67 3.83 4.10 4.66 3.03
Days Sales Outstanding (DSO)
0.00 18.26 59.47 58.03 64.05 119.63 76.97 61.47 58.14 56.39 66.48
Days Inventory Outstanding (DIO)
69.50 25.88 24.95 36.52 26.14 61.47 38.45 22.07 22.19 22.16 27.21
Days Payable Outstanding (DPO)
74.23 53.59 55.60 84.23 55.78 125.61 99.35 95.35 88.94 78.37 120.55
Cash Conversion Cycle (CCC)
-4.74 -9.45 28.82 10.32 34.40 55.49 16.07 -11.80 -8.61 0.18 -26.87
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
42,992 62,167 65,635 66,837 70,573 71,687 54,974 63,589 68,585 72,382 76,994
Invested Capital Turnover
0.24 1.19 0.53 0.54 0.50 0.23 0.28 0.32 0.33 0.33 0.33
Increase / (Decrease) in Invested Capital
-5,047 19,175 3,468 1,202 3,736 1,114 -16,713 8,615 4,996 3,797 4,802
Enterprise Value (EV)
44,709 68,879 75,289 83,250 87,581 87,140 100,590 90,910 87,684 94,803 123,782
Market Capitalization
24,876 33,349 39,550 47,027 49,232 47,455 67,281 52,065 44,854 49,342 57,379
Book Value per Share
$21.19 $21.02 $23.60 $24.15 $25.21 $25.42 $26.78 $19.04 $0.00 $0.00 $0.00
Tangible Book Value per Share
$19.00 $15.59 $18.33 $18.90 $19.99 $20.22 $21.62 $13.94 ($5.09) ($5.06) ($5.04)
Total Capital
52,972 62,884 67,380 69,185 71,982 73,811 68,945 64,794 69,763 73,570 96,664
Total Debt
25,678 35,272 35,193 36,138 37,409 38,943 34,150 40,050 44,008 46,649 67,866
Total Long-Term Debt
23,645 31,575 32,176 34,075 31,329 35,093 30,749 35,662 40,082 43,337 65,589
Net Debt
18,332 33,755 33,448 33,917 36,000 37,402 32,907 38,845 42,830 45,461 66,403
Capital Expenditures (CapEx)
7,477 8,492 7,365 7,594 7,195 8,002 7,104 7,131 7,383 7,059 8,525
Debt-free, Cash-free Net Working Capital (DFCFNWC)
1,542 1,764 3,010 2,391 2,987 2,540 254 140 1,185 1,187 341
Debt-free Net Working Capital (DFNWC)
8,249 2,652 4,115 3,987 3,932 3,641 1,247 1,113 2,112 2,085 1,492
Net Working Capital (NWC)
6,216 -1,045 1,098 1,924 -2,148 -209 -2,154 -3,275 -1,814 -1,227 -785
Net Nonoperating Expense (NNE)
1,079 20,156 665 1,606 496 251 791 663 1,138 1,524 1,562
Net Nonoperating Obligations (NNO)
15,698 34,555 33,448 33,790 36,000 36,819 20,179 38,845 42,830 45,461 48,196
Total Depreciation and Amortization (D&A)
3,987 5,576 5,427 5,971 5,780 6,527 7,573 3,533 3,506 3,596 3,643
Debt-free, Cash-free Net Working Capital to Revenue
13.95% 2.81% 8.97% 6.65% 8.67% 15.24% 1.42% 0.73% 5.45% 5.15% 1.41%
Debt-free Net Working Capital to Revenue
74.64% 4.23% 12.26% 11.08% 11.42% 21.85% 6.95% 5.83% 9.72% 9.05% 6.15%
Net Working Capital to Revenue
56.24% -1.67% 3.27% 5.35% -6.24% -1.25% -12.01% -17.17% -8.35% -5.33% -3.24%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $2.83 $1.48 $2.15 $1.43 $1.74 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
1.25B 1.30B 1.33B 1.36B 1.37B 1.37B 979M 986M 996M 1.00B 1.01B
Adjusted Diluted Earnings per Share
$0.00 $0.87 $2.83 $1.47 $2.14 $1.43 $1.74 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
1.25B 1.30B 1.33B 1.36B 1.37B 1.37B 980M 987M 997M 1.00B 1.01B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
1.25B 2.09B 2.14B 1.79B 0.00 3.60B 1.29B 1.30B 1.31B 1.31B 1.33B
Normalized Net Operating Profit after Tax (NOPAT)
1,911 21,381 2,906 3,632 3,499 1,525 2,620 2,835 3,458 3,973 4,327
Normalized NOPAT Margin
17.29% 34.11% 8.66% 10.09% 10.16% 9.15% 14.61% 14.86% 15.91% 17.25% 17.84%
Pre Tax Income Margin
30.13% 3.15% 11.25% 6.18% 11.57% 6.55% 9.22% 12.60% 12.44% 11.58% 13.57%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 22.67 3.42 2.43 3.47 1.84 2.28 2.66 2.56 2.39 2.55
NOPAT to Interest Expense
0.00 13.90 2.91 2.37 2.18 1.69 2.03 1.96 2.00 2.08 2.04
EBIT Less CapEx to Interest Expense
0.00 17.15 -1.30 -2.46 -0.99 -4.29 -3.23 -2.27 -1.71 -1.29 -1.46
NOPAT Less CapEx to Interest Expense
0.00 8.37 -1.81 -2.52 -2.27 -4.44 -3.48 -2.97 -2.27 -1.61 -1.97
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
66.21% 98.16% 31.95% 64.07% 46.50% 76.36% 130.24% 61.45% 61.56% 61.95% 58.42%
Augmented Payout Ratio
66.21% 98.16% 31.95% 64.07% 46.50% 76.36% 130.24% 61.45% 61.56% 61.95% 58.42%

Quarterly Metrics And Ratios for Exelon

This table displays calculated financial ratios and metrics derived from Exelon's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 1,329,256,191.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 1,329,256,191.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 0.69
Growth Metrics
- - - - - - - - - - -
Revenue Growth
23.43% 0.00% 8.63% 11.27% 2.91% 1.94% 0.00% 1.23% 8.95% -1.06% 7.86%
EBITDA Growth
6.89% 141.10% -0.29% 9.42% 3.30% 0.78% 2.84% 1.18% 14.75% 5.73% 5.38%
EBIT Growth
6.27% 0.00% -2.14% 15.90% 4.07% -0.60% 0.00% 1.54% 25.14% 9.29% 5.42%
NOPAT Growth
15.17% 0.00% 10.33% 42.64% 8.99% 8.80% 0.00% -5.04% 14.08% -4.45% 1.88%
Net Income Growth
3.55% 0.00% -1.64% 30.61% 1.00% 5.03% -16.67% -12.72% 23.76% -8.19% 1.21%
EPS Growth
0.00% 0.00% -1.49% 32.35% 0.00% 0.00% 36.36% -13.33% 22.86% 0.00% 0.00%
Operating Cash Flow Growth
-59.03% 93.55% 104.96% 14.49% 10.32% 1.06% 20.97% 3.35% 36.12% -12.76% 43.67%
Free Cash Flow Firm Growth
91.88% 52.89% 0.00% 99.08% 53.10% 31.58% 94.22% -464.82% -28.68% -47.95% -32.24%
Invested Capital Growth
10.17% 7.86% 0.00% 2.11% 5.27% 5.54% 5.78% 6.17% 6.21% 6.65% 6.70%
Revenue Q/Q Growth
24.12% -10.27% 12.62% -11.29% 14.79% -11.11% -100.00% -19.17% 23.55% -19.28% 33.81%
EBITDA Q/Q Growth
22.40% -1.62% 0.49% -9.57% 15.55% -4.02% -56.39% -24.07% 31.06% -11.57% 19.74%
EBIT Q/Q Growth
42.82% -2.91% 1.71% -17.83% 28.25% -7.26% -100.00% -37.53% 58.06% -19.01% 31.81%
NOPAT Q/Q Growth
76.57% -8.50% 8.41% -18.56% 34.91% -8.66% -100.00% -39.23% 62.07% -23.49% 35.21%
Net Income Q/Q Growth
104.08% -12.00% 6.82% -31.91% 57.81% -8.49% -101.08% -56.94% 123.79% -32.11% 54.71%
EPS Q/Q Growth
105.88% -11.43% 6.45% -31.82% 55.56% 0.00% 0.00% -56.67% 120.51% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
19.89% -7.84% -29.70% 47.38% 15.53% -15.57% -15.85% 25.92% 52.15% -45.89% 38.59%
Free Cash Flow Firm Q/Q Growth
92.38% 22.32% -1,598.83% 99.08% -287.65% -13.33% -45.75% -29.66% 11.68% -21.39% 4.87%
Invested Capital Q/Q Growth
-2.12% 1.33% 2.00% 0.93% 0.91% 1.59% 2.24% 1.30% 0.95% 1.74% 2.56%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
59.92% -22.72% 60.12% 62.84% 61.28% -25.01% 0.00% 40.72% 42.37% 46.53% 41.43%
EBITDA Margin
35.00% 38.37% 34.24% 34.90% 35.13% 37.93% 0.00% 34.88% 37.00% 40.54% 36.27%
Operating Margin
18.78% 20.31% 18.43% 17.03% 19.43% 20.04% 0.00% 17.08% 22.37% 21.90% 22.16%
EBIT Margin
20.13% 21.79% 19.68% 18.22% 20.36% 21.24% 0.00% 18.28% 23.39% 23.47% 23.12%
Profit (Net Income) Margin
11.71% 11.48% 10.89% 8.36% 11.49% 11.83% 0.00% 7.20% 13.05% 10.98% 12.69%
Tax Burden Percent
91.26% 86.03% 91.26% 90.69% 93.40% 93.09% 100.00% 84.82% 84.95% 82.27% 82.13%
Interest Burden Percent
63.70% 61.25% 60.64% 50.56% 60.42% 59.81% 0.00% 46.47% 65.69% 56.85% 66.85%
Effective Tax Rate
8.74% 13.97% 8.74% 9.31% 6.61% 6.91% 0.00% 15.18% 15.05% 17.73% 17.87%
Return on Invested Capital (ROIC)
0.00% 5.75% 10.68% 5.03% 5.99% 6.09% 0.00% 4.73% 6.29% 5.86% 5.90%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 4.96% 9.05% 4.17% 5.05% 5.25% 0.00% 3.87% 5.42% 5.04% 5.07%
Return on Net Nonoperating Assets (RNNOA)
0.00% 8.02% 15.24% 7.21% 8.41% 8.80% 0.00% 6.61% 9.14% 8.46% 8.55%
Return on Equity (ROE)
0.00% 13.76% 25.92% 12.23% 14.40% 14.89% 0.00% 11.34% 15.43% 14.32% 14.45%
Cash Return on Invested Capital (CROIC)
-9.68% -2.31% -189.81% 3.36% 0.48% 0.27% 0.38% -0.19% -0.07% -0.63% -0.79%
Operating Return on Assets (OROA)
0.00% 4.80% 8.47% 4.08% 4.55% 4.67% 0.00% 4.02% 5.18% 5.07% 5.05%
Return on Assets (ROA)
0.00% 2.53% 4.69% 1.87% 2.57% 2.60% 0.00% 1.58% 2.89% 2.37% 2.77%
Return on Common Equity (ROCE)
0.00% 6.74% 25.92% 12.23% 14.40% 0.00% 0.00% 11.34% 15.43% 0.00% 14.45%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 8.89% 9.26% 9.12% 0.00% 8.91% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
1,025 938 1,017 828 1,117 1,020 0.00 786 1,274 975 1,318
NOPAT Margin
17.14% 17.48% 16.82% 15.44% 18.15% 18.65% 0.00% 14.49% 19.00% 18.01% 18.20%
Net Nonoperating Expense Percent (NNEP)
0.82% 0.79% 1.63% 0.86% 0.94% 0.85% 0.02% 0.86% 0.87% 0.82% 0.83%
Return On Investment Capital (ROIC_SIMPLE)
- 1.34% - - - 1.39% 0.00% 1.03% 1.63% 1.01% 1.64%
Cost of Revenue to Revenue
40.08% 122.72% 39.88% 37.16% 38.72% 125.01% 0.00% 59.28% 57.63% 53.47% 58.58%
SG&A Expenses to Revenue
19.85% 0.00% 21.03% 22.55% 20.72% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
41.14% -43.03% 41.68% 45.94% 41.84% -45.17% 0.00% 23.64% 20.00% 24.63% 19.26%
Earnings before Interest and Taxes (EBIT)
1,204 1,169 1,189 977 1,253 1,162 0.00 992 1,568 1,270 1,674
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
2,093 2,059 2,069 1,871 2,162 2,075 905 1,893 2,481 2,194 2,627
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.85 0.00 1.84 1.71 1.99 0.00 2.19 2.07 2.11 0.00 2.22
Price to Tangible Book Value (P/TBV)
2.51 0.00 2.47 2.29 2.65 0.00 2.88 2.72 2.76 0.00 2.87
Price to Revenue (P/Rev)
0.00 2.06 2.16 1.97 2.31 2.14 2.62 2.40 2.44 2.37 2.63
Price to Earnings (P/E)
0.00 19.27 20.68 18.47 21.81 20.06 22.30 21.53 21.00 20.73 23.44
Dividend Yield
3.90% 4.18% 3.97% 4.32% 3.70% 4.04% 3.34% 3.59% 3.51% 3.67% 3.30%
Earnings Yield
0.00% 5.19% 4.84% 5.41% 4.58% 4.99% 4.49% 4.64% 4.76% 4.82% 4.27%
Enterprise Value to Invested Capital (EV/IC)
1.32 1.28 1.31 1.26 1.37 1.31 1.44 1.39 1.41 1.61 1.45
Enterprise Value to Revenue (EV/Rev)
0.00 4.04 4.13 3.92 4.26 4.12 4.64 4.40 4.39 5.10 4.63
Enterprise Value to EBITDA (EV/EBITDA)
25.78 11.05 11.58 11.02 11.96 11.59 13.45 12.12 11.94 13.66 12.48
Enterprise Value to EBIT (EV/EBIT)
0.00 19.79 20.84 19.65 21.27 20.69 24.73 20.91 20.11 22.85 20.86
Enterprise Value to NOPAT (EV/NOPAT)
0.00 25.30 25.76 23.44 25.04 23.80 24.73 24.77 24.43 28.59 26.38
Enterprise Value to Operating Cash Flow (EV/OCF)
22.25 18.64 17.62 16.53 17.57 17.02 18.49 17.93 16.59 19.79 16.94
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 38.02 295.41 507.56 392.73 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.70 1.71 1.74 1.77 1.73 1.73 1.75 1.77 1.78 2.36 1.75
Long-Term Debt to Equity
1.56 1.56 1.64 1.66 1.66 1.61 1.66 1.66 1.66 2.28 1.65
Financial Leverage
1.58 1.62 1.68 1.73 1.67 1.68 1.68 1.71 1.68 1.68 1.69
Leverage Ratio
3.85 3.91 3.96 3.97 3.94 3.98 3.96 4.02 4.01 4.03 3.99
Compound Leverage Factor
2.45 2.39 2.40 2.01 2.38 2.38 0.00 1.87 2.64 2.29 2.67
Debt to Total Capital
62.91% 63.08% 63.52% 63.85% 63.38% 63.41% 63.62% 63.88% 63.97% 70.21% 63.61%
Short-Term Debt to Total Capital
4.91% 5.63% 3.79% 3.82% 2.73% 4.50% 3.34% 3.83% 4.16% 2.36% 3.71%
Long-Term Debt to Total Capital
57.99% 57.45% 59.72% 60.03% 60.65% 58.91% 60.27% 60.05% 59.81% 67.85% 59.90%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
37.09% 0.00% 36.48% 36.15% 36.62% 0.00% 36.38% 36.12% 36.03% 0.00% 36.39%
Debt to EBITDA
12.45 5.54 5.72 5.71 5.65 5.70 6.08 5.66 5.58 7.49 5.57
Net Debt to EBITDA
12.17 5.40 5.54 5.49 5.47 5.56 5.84 5.49 5.32 7.33 5.40
Long-Term Debt to EBITDA
11.48 5.05 5.38 5.37 5.40 5.30 5.76 5.32 5.22 7.24 5.25
Debt to NOPAT
0.00 12.70 12.73 12.14 11.82 11.71 11.18 11.58 11.42 15.67 11.78
Net Debt to NOPAT
0.00 12.36 12.31 11.68 11.45 11.41 10.74 11.23 10.88 15.34 11.41
Long-Term Debt to NOPAT
0.00 11.56 11.97 11.41 11.31 10.88 10.59 10.89 10.67 15.15 11.09
Altman Z-Score
0.48 0.66 0.71 0.67 0.74 0.69 0.75 0.74 0.76 0.72 0.79
Noncontrolling Interest Sharing Ratio
0.00% 51.00% 0.00% 0.00% 0.00% 100.00% 0.00% 0.00% 0.00% 100.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.85 0.82 1.03 1.03 1.09 0.87 1.09 0.95 0.94 0.92 0.94
Quick Ratio
0.41 0.38 0.54 0.56 0.58 0.43 0.62 0.53 0.56 0.55 0.56
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-5,224 -4,058 -68,942 -632 -2,450 -2,777 -4,047 -3,570 -3,153 -3,827 -3,641
Operating Cash Flow to CapEx
82.53% 76.56% 56.20% 86.05% 99.65% 73.66% 61.67% 75.14% 107.63% 51.15% 73.11%
Free Cash Flow to Firm to Interest Expense
-11.95 -8.96 -147.31 -1.31 -4.94 -5.95 -578.14 -6.72 -5.86 -6.98 -6.56
Operating Cash Flow to Interest Expense
3.50 3.11 2.12 3.03 3.41 3.05 171.43 2.85 4.27 2.27 3.11
Operating Cash Flow Less CapEx to Interest Expense
-0.74 -0.95 -1.65 -0.49 -0.01 -1.09 -106.57 -0.94 0.30 -2.17 -1.14
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.00 0.22 0.43 0.22 0.22 0.22 0.22 0.22 0.22 0.22 0.22
Accounts Receivable Turnover
0.00 6.28 0.00 6.66 6.57 6.47 6.06 6.08 6.35 5.49 5.69
Inventory Turnover
0.00 16.45 0.00 17.45 16.54 16.47 16.81 16.34 16.10 13.41 16.94
Fixed Asset Turnover
0.00 0.30 0.00 0.31 0.31 0.30 0.30 0.30 0.31 0.30 0.30
Accounts Payable Turnover
0.00 4.10 0.00 0.00 5.01 4.66 4.94 4.72 4.76 3.03 4.88
Days Sales Outstanding (DSO)
0.00 58.14 0.00 54.82 55.52 56.39 60.24 60.07 57.48 66.48 64.12
Days Inventory Outstanding (DIO)
0.00 22.19 0.00 20.92 22.07 22.16 21.72 22.33 22.67 27.21 21.55
Days Payable Outstanding (DPO)
0.00 88.94 0.00 0.00 72.92 78.37 73.91 77.38 76.70 120.55 74.74
Cash Conversion Cycle (CCC)
0.00 -8.61 0.00 75.74 4.67 0.18 8.05 5.02 3.45 -26.87 10.93
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
67,684 68,585 69,959 70,609 71,251 72,382 74,006 74,965 75,678 76,994 78,965
Invested Capital Turnover
0.00 0.33 0.63 0.33 0.33 0.33 0.32 0.33 0.33 0.33 0.32
Increase / (Decrease) in Invested Capital
6,249 4,996 69,959 1,460 3,567 3,797 4,047 4,356 4,427 4,802 4,959
Enterprise Value (EV)
89,454 87,684 91,819 89,202 97,609 94,803 106,822 104,468 106,800 123,782 114,795
Market Capitalization
47,240 44,854 47,921 44,745 52,980 49,342 60,423 57,123 59,235 57,379 65,145
Book Value per Share
$19.57 $0.00 $26.06 $20.02 $20.38 $0.00 $21.05 $20.99 $21.36 $0.00 $22.06
Tangible Book Value per Share
$14.48 ($5.09) $19.43 $14.95 $15.30 ($5.06) $16.00 $15.95 $16.32 ($5.04) $17.07
Total Capital
68,665 69,763 71,431 72,343 72,698 73,570 75,877 76,464 78,034 96,664 80,555
Total Debt
43,195 44,008 45,370 46,191 46,076 46,649 48,270 48,844 49,921 67,866 51,240
Total Long-Term Debt
39,821 40,082 42,661 43,429 44,091 43,337 45,732 45,917 46,673 65,589 48,249
Net Debt
42,214 42,830 43,898 44,457 44,629 45,461 46,399 47,345 47,565 66,403 49,650
Capital Expenditures (CapEx)
1,855 1,843 1,765 1,699 1,695 1,936 1,946 2,011 2,136 2,432 2,358
Debt-free, Cash-free Net Working Capital (DFCFNWC)
1,358 1,185 1,737 1,580 1,456 1,187 1,652 1,245 603 341 1,132
Debt-free Net Working Capital (DFNWC)
2,093 2,112 2,946 3,044 2,624 2,085 3,234 2,447 2,652 1,492 2,405
Net Working Capital (NWC)
-1,281 -1,814 237 282 639 -1,227 696 -480 -596 -785 -586
Net Nonoperating Expense (NNE)
325 322 359 380 410 373 7.00 395 399 381 399
Net Nonoperating Obligations (NNO)
42,214 42,830 43,898 44,457 44,629 45,461 46,399 47,345 47,565 48,196 49,650
Total Depreciation and Amortization (D&A)
889 890 880 894 909 913 905 901 913 924 953
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 5.45% 7.82% 6.95% 6.35% 5.15% 7.17% 5.24% 2.48% 1.41% 4.57%
Debt-free Net Working Capital to Revenue
0.00% 9.72% 13.27% 13.38% 11.45% 9.05% 14.04% 10.30% 10.91% 6.15% 9.70%
Net Working Capital to Revenue
0.00% -8.35% 1.07% 1.24% 2.79% -5.33% 3.02% -2.02% -2.45% -3.24% -2.36%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.62 $0.66 $0.45 $0.70 $0.00 $0.90 $0.39 $0.87 $0.00 $0.90
Adjusted Weighted Average Basic Shares Outstanding
996M 996M 1B 1.00B 1.00B 1.00B 1.01B 1.01B 1.01B 1.01B 1.02B
Adjusted Diluted Earnings per Share
$0.00 $0.62 $0.66 $0.45 $0.70 $0.00 $0.90 $0.39 $0.86 $0.00 $0.90
Adjusted Weighted Average Diluted Shares Outstanding
997M 997M 1.00B 1.00B 1.00B 1.00B 1.01B 1.01B 1.01B 1.01B 1.03B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.62 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
1.30B 1.31B 1.31B 1.31B 1.31B 1.31B 1.32B 1.32B 1.32B 1.33B 1.33B
Normalized Net Operating Profit after Tax (NOPAT)
1,025 938 1,015 828 1,114 1,020 0.00 785 1,274 973 1,318
Normalized NOPAT Margin
17.14% 17.48% 16.79% 15.44% 18.11% 18.65% 0.00% 14.46% 19.00% 17.98% 18.20%
Pre Tax Income Margin
12.83% 13.34% 11.93% 9.21% 12.30% 12.71% 0.00% 8.49% 15.36% 13.34% 15.45%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
2.76 2.58 2.54 2.02 2.53 2.49 0.00 1.87 2.91 2.32 3.02
NOPAT to Interest Expense
2.35 2.07 2.17 1.71 2.25 2.18 0.00 1.48 2.37 1.78 2.38
EBIT Less CapEx to Interest Expense
-1.49 -1.49 -1.23 -1.49 -0.89 -1.66 -278.00 -1.92 -1.06 -2.12 -1.23
NOPAT Less CapEx to Interest Expense
-1.90 -2.00 -1.60 -1.80 -1.17 -1.96 -278.00 -2.31 -1.60 -2.66 -1.87
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 61.56% 62.84% 60.98% 61.80% 61.95% 62.87% 59.22% 56.50% 58.42% 59.16%
Augmented Payout Ratio
0.00% 61.56% 62.84% 60.98% 61.80% 61.95% 62.87% 59.22% 56.50% 58.42% 59.16%

Financials Breakdown Chart

Key Financial Trends

Key observations for EXC (Exelon) from 2022–2025 across income statements, cash flows, and balance sheets. The points focus on profitability, liquidity, leverage, and capital activity that could matter to retail investors.

  • Operating cash flow remains positive and sizable. Quarterly net cash from continuing operating activities ranges around 1.1B–2.3B in 2023–2025, with a peak in 2025 Q3 (~2.3B). This ongoing positive cash flow supports liquidity and capability to fund capex and debt service.
  • Net income to common shareholders generally positive over the period. Across 2022–2025, consolidated net income attributable to common shareholders is typically positive (examples: 2025 Q4 about 594M; 2024 Q4 about 647M; 2023 Q4 around 708–908M in restated data). This suggests profitability at the equity level despite quarterly fluctuations in continuing operations.
  • Capital expenditure intensity remains high, signaling ongoing infrastructure investments. Quarterly purchases of property, plant & equipment have been substantial (roughly $1.9B–$2.5B per quarter in 2023–2025), consistent with a strategy to grow or maintain rate base and reliability.
  • Regular, visible dividend per share supports income-focused investors. Cash dividends per share have trended in a modest range (roughly $0.34–$0.40 per share across 2022–2025), indicating a steady payout policy alongside earnings.
  • Top-line revenue has been relatively stable but not driving rapid growth. Operating revenue has generally sat in the mid‑single to high single digits billions across quarters (roughly $5.4B–$6.7B range in 2023–2025), indicating stable but not accelerating growth.
  • Balance sheet shows a massive asset base and leverage typical of a large utility. The company carries a very large asset base, long-term investments, and substantial liabilities, reflecting a capital-intensive business model with meaningful debt and noncurrent obligations.
  • Net income from continuing operations can swing to losses in some quarters. Notably, 2025 Q4 shows a continuing-operations loss (approximately -2.17B), highlighting earnings volatility and potential one-time charges that can weigh near-term profitability.
  • Investing activity often dominates cash flow, pressuring near-term liquidity. Large investing cash outflows (PPE purchases and other investing activities) frequently exceed operating cash flow in several periods, which can pressure liquidity if financing conditions worsen.
  • Long-term debt remains substantial, creating interest burden and balance-sheet leverage. Long-term debt typically sits in the mid-to-high $40B range, contributing to a sizable liabilities load and ongoing interest costs in a rising-rate environment.
  • Cash balance can shrink in late-year quarters due to heavy capex and financing activity. Net change in cash and equivalents was negative in key 2025 quarters, signaling that cash on hand can dip when investing and financing outflows are high.
05/08/26 06:41 AM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Exelon's Financials

When does Exelon's financial year end?

According to the most recent income statement we have on file, Exelon's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

How has Exelon's net income changed over the last 10 years?
The last 5 years of Exelon's net income performance:
  • 2021: $1.83 billion
  • 2022: $2.17 billion
  • 2023: $2.33 billion
  • 2024: $2.46 billion
  • 2025: $2.77 billion
Find out what analysts predict for Exelon in the coming months.
What is Exelon's operating income?
Exelon's total operating income in 2025 was $5.15 billion, based on the following breakdown:
  • Total Gross Profit: $10.41 billion
  • Total Operating Expenses: $5.27 billion
How has Exelon's revenue changed over the last 10 years?

Over the last 10 years, Exelon's total revenue changed from $11.05 billion in 2015 to $24.26 billion in 2025, a change of 119.5%.

How much debt does Exelon have?

Exelon's total liabilities were at $87.77 billion at the end of 2025, a 8.5% increase from 2024, and a 29.0% increase since 2015.

How much cash does Exelon have?

In the past 10 years, Exelon's cash and equivalents has ranged from $357 million in 2024 to $6.50 billion in 2015, and is currently $626 million as of their latest financial filing in 2025.

How has Exelon's book value per share changed over the last 10 years?

Over the last 10 years, Exelon's book value per share changed from 21.19 in 2015 to 0.00 in 2025, a change of -100.0%.



Financial statements for NASDAQ:EXC last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners